REVOSHIELD+ Trademark

Trademark Overview


On Wednesday, August 20, 2025, a trademark application was filed for REVOSHIELD+ with the United States Patent and Trademark Office. The USPTO has given the REVOSHIELD+ trademark a serial number of 99347237. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, January 9, 2026. This trademark is owned by RevoGen Biologics, LLC. The REVOSHIELD+ trademark is filed in the Pharmaceutical Products category with the following description:

Dual layer amnion patch
revoshield+

General Information


Serial Number99347237
Word MarkREVOSHIELD+
Filing DateWednesday, August 20, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, January 9, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDual layer amnion patch
Pseudo MarkREVO SHIELD PLUS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 20, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRevoGen Biologics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSan Antonio, TX 78240

Trademark Events


Event DateEvent Description
Wednesday, August 20, 2025NEW APPLICATION ENTERED
Wednesday, August 20, 2025APPLICATION FILING RECEIPT MAILED
Thursday, January 8, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 9, 2026ASSIGNED TO EXAMINER
Friday, January 9, 2026NON-FINAL ACTION WRITTEN
Friday, January 9, 2026NON-FINAL ACTION E-MAILED
Friday, January 9, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords


revoshield patch amnion layer dual